US Researchers Find Immune Defect May Have a Role in Alzheimer's Disease
Posted on: Saturday, 11 June 2005, 09:00 CDT
US researchers find immune defect may have a role in Alzheimer's disease
LOS ANGELES, June 10 (Xinhua) -- US researchers said on Friday that they have found some patients with Alzheimer's disease have an immune defect making them prone to the disease.
Researchers at the University of California in Los Angeles ( UCLA)said they found that the immune defect makes it difficult to clean the brain of waste products that can form the definitive hallmark of the disease.
In findings published in the Journal of Alzheimer's Disease, researchers said the immune defect may lead to over-saturation of the brain with amyloid-beta, which form amyloid plaques.
It marks the first time researchers have discovered that the innate -- or more primitive -- part of the immune system may play a role in the development of Alzheimer's disease, scientists said.
The findings could lead to a new approach in diagnosing and correcting the immune defect, according to researchers.
Scientists using blood samples found that in healthy people, cells belonging to the innate immune system called macrophages cleared amyloid-beta in a test tube test developed at UCLA, researchers said.
The macrophages of some Alzheimer's patients, however, could not adequately perform the cleaning job.
''Macrophages are the janitors of the innate immune system, gobbling up waste products in the brain and throughout the body,'' said Milan Fiala, a researcher at UCLA.
The immune defect also may have a role in other diseases involving a build-up of waste and plaques, such as in cardiovascular disease and Gaucher's disease, he said.
''If further study shows that this defective macrophage function is present in most Alzheimer's disease patients, new hormonal or immune-boosting approaches may offer new approaches to treating the disease,'' Fiala said.
Source: Xinhua News Agency - CEIS
Related Articles
- Leading Alzheimer's Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science
- ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinson's Disease Research to Develop Tolls for Imaging Alpha-Synuclein Aggregation in Living Parkinson's Brain
- Two Scientists Honored with MetLife Foundation Awards for Medical Research in Alzheimer's Disease
- MetLife Foundation Announces Major Awards to Scientists for Research in Alzheimer's Disease
- Video: Alzheimer's Disease Research Grants Two $1 Million Centennial Awards
- Over 300 Different Compounds Are at Various Stages of Development for the Treatment of Alzheimer's Disease - Research in Alzheimer's Disease 2007
- ADDING MULTIMEDIA MetLife Foundation Marks 20th Anniversary of Awards for Medical Research in Alzheimer's Disease; Two Decades of Investing in Science and Scientists
- U-M Health System Receives $10M Grant for Alzheimer's Disease Research
- New Research Shows Aspect Medical Systems' Brain Monitoring Technology Correlates With Measures of Alzheimer's Disease and Dementia
 |
 |
User Comments (0)
RSS Feeds